Nucleus CEO, Logan Lenz, sits down with Stefan von Imhof, the CEO of Alts.co to discuss Nucleus and the massive opportunity for the psychedelics industry in the coming years.

A few months back, Alts published a deep dive on Nucleus, a venture studio for psychedelics (and Psychedelic Invest’s parent company).

Stefan is the co-founder and CEO of Alts.co. He’s a huge fan of alternative investing and has a strong background in alternative asset analysis and valuations. Prior to co-founding Alts.co, Stefan was Head of Product at Flippa where he created Flippa’s Due Diligence Program, He also spent time at Citrix and lynda.com, which was bought by LinkedIn, and was the first product manager at HG Insights, a market intelligence company that sold to Riverwood Capital Partners in 2020. Originally from Boston and later Santa Barbara, CA, he now lives in Australia with his wife & Boston Terrier, Charlie.

More About Alts.co

Alts.co provides original research and insights you can trust on alternative assets. Over 85,000 subscribers are delivered investment opportunities and insights straight to their inbox.

Investing in Nucleus

For those who don’t know by now, Nucleus currently allows anyone to invest in the company with as little as $200. All you must do is visit the Wefunder page, select your investment amount, and go through Wefunder’s transaction process.

Stay tuned for more Nucleus events and webinars as the campaign continues.

RSVP To Reserve Your Spot